Rucaparib Synthesis Route for Higher Yield and Reproducibility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthetic methods for rucaparib suffer from low synthesis yield and reproducibility issues, particularly in the production of indoloazepine compounds, which hampers the marketability and potential applications of the drug for various cancers.
Innovation Solution
A novel synthetic method involving the synthesis of an indole skeleton with substituents at positions 2, 3, 4, and 6, followed by a heptagonal lactam ring formation and simultaneous reduction of the cyano group to introduce a lactam and amine group, using 4-cyanobenzaldehyde, with specific catalysts and dehydrating agents to enhance yield and reproducibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the existing linear synthetic route is used, then the production process is simple, but the synthesis yield is low and reproducibility is poor
Solution Approach 1:
The synthesis route is divided into distinct modular steps: (1) condensation of 4-cyanobenzaldehyde with amino compound to form indole skeleton, (2) reduction of cyano group to amine, (3) cyclization to form lactam ring, and (4) deprotection. This segmentation allows each step to be optimized independently, improving overall yield and reproducibility while maintaining reasonable process complexity.
Solution Approach 2:
The indole skeleton is synthesized first with all necessary substituents in place before performing the lactam ring formation. This preliminary construction of the core structure allows subsequent transformations to proceed more efficiently, improving yield and reducing the number of steps needed for final product formation.
2Reliability
If the existing synthetic method is used, then the process is established, but reproducibility and synthesis yield are insufficient for mass production
Solution Approach 1:
Specific reaction parameters are optimized: (1) use of catalytic amounts of acid or base catalysts for condensation, (2) controlled reduction conditions for cyano group transformation, (3) specific cyclization conditions for lactam formation, and (4) controlled deprotection. These parameter optimizations improve both reproducibility and yield consistently across multiple production batches.
3Productivity
If multiple steps are performed sequentially, then the synthesis is thorough, but the production time and cost increase
Solution Approach 1:
Multiple transformations are merged into consolidated steps: the condensation and cyclization steps are performed in sequence without isolation, and the reduction and cyclization steps are combined when possible. This merging reduces the total number of work-up operations and time required while maintaining thorough synthesis of the target molecule.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves superior synthesis yield and reproducibility, offering cost efficiency and easy product separation through recrystallization, enhancing the production of rucaparib for cancer treatment.
Implementation Method 1
reacting a compound of Chemical Formula (1) and a compound of Chemical Formula (2), and converting the result into a compound of Chemical Formula (3) in the presence of a catalyst
Implementation Method 2
the step of conversion into the compound of Chemical Formula (3) is preferably performed in the presence of a dehydrating agent. Using such a dehydrating agent may facilitate the overall reaction by removing water molecules generated when forming an imine intermediate
Implementation Method 3
simultaneously reducing the cyano group to introduce both a lactam and an amine group
Data Source
AI summary
The present disclosure relates to an improved method for preparing rucaparib capable of achieving excellent synthesis yield and reproducibility. In particular, the present disclosure relates to an improved method for synthesizing Rucaparib and a novel intermediate that can be used in its preparation. The method offers the advantage of using of 4-cyanobenzaldehyde in the synthesis of an indole skeleton with substituents introduced at the 2, 3, 4, and 6 positions and then, simultaneously reducing the cyano group to introduce both a lactam and an amine group, and also relates to a novel intermediate that can be used in its preparation.